BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15922607)

  • 1. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
    Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
    Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
    Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
    Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolism of glycosaminoglycans is impaired in prion diseases.
    Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
    Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of disease-associated prion protein to plasminogen.
    Fischer MB; Roeckl C; Parizek P; Schwarz HP; Aguzzi A
    Nature; 2000 Nov; 408(6811):479-83. PubMed ID: 11100730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
    Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
    Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K].
    Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.
    Kang SC; Brown DR; Whiteman M; Li R; Pan T; Perry G; Wisniewski T; Sy MS; Wong BS
    J Pathol; 2004 May; 203(1):603-8. PubMed ID: 15095484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
    Saborio GP; Permanne B; Soto C
    Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal host prion protein necessary for scrapie-induced neurotoxicity.
    Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A
    Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional and phenotype heterogeneity of cellular prion proteins in the human brain.
    Kuczius T; Koch R; Keyvani K; Karch H; Grassi J; Groschup MH
    Eur J Neurosci; 2007 May; 25(9):2649-55. PubMed ID: 17466020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural localization of prion proteins: physiological and pathological implications.
    Fournier JG; Escaig-Haye F; Grigoriev V
    Microsc Res Tech; 2000 Jul; 50(1):76-88. PubMed ID: 10871551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner.
    Ellis V; Daniels M; Misra R; Brown DR
    Biochemistry; 2002 Jun; 41(22):6891-6. PubMed ID: 12033920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species.
    Díaz-San Segundo F; Salguero FJ; de Avila A; Espinosa JC; Torres JM; Brun A
    Acta Neuropathol; 2006 Nov; 112(5):587-95. PubMed ID: 16957924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
    Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
    EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.